City advisers are poised to earn up to £163 million in fees from the acquisition of Tate & Lyle by Ingredion, an Illinois-based manufacturer of starches and sweeteners. The £2.7 billion deal marks the takeover of one of London’s longest-listed companies, with Ingredion’s cash offer approved by Tate & Lyle’s board.

Ingredion’s bid values Tate & Lyle’s shares at 595 pence each, representing a 58.7 percent premium over the company’s closing share price of 374¾ pence on May 13, 2026. Tate & Lyle, established 165 years ago, remains the only original constituent of the FT30 index, a precursor to the FTSE 100.

Tate & Lyle is expected to incur fees of up to £64.2 million in connection with the transaction. Financial and corporate broking services account for £40.3 million of this total, divided among Goldman Sachs and Greenhill—who are leading advisers on the deal—and Bank of America and Citigroup, which serve as joint financial advisers and corporate brokers. Legal counsel for Tate & Lyle, provided by Linklaters, will generate fees estimated at £22 million, while FTI Consulting, responsible for communications, will receive up to £1 million.

Ingredion will cover fees and expenses estimated at $132.3 million, including $44.1 million in financing fees and up to $34 million paid to its sole financial adviser, JP Morgan. Hogan Lovells is expected to receive $19.9 million in legal fees for its role in the transaction. Additional costs borne by Ingredion will include payments to public relations firms, accountants, and associated stamp duties.

The transaction highlights a surge in dealmaking activity, with total deal values reaching $230.9 billion in the first half of 2026. This amount reflects a 210 percent increase compared to the same period last year, underscoring a highly active market for corporate mergers and acquisitions.